Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial

Author:

Dutton Susan J,Ferry David R,Blazeby Jane M,Abbas Haider,Dahle-Smith Asa,Mansoor Wasat,Thompson Joyce,Harrison Mark,Chatterjee Anirban,Falk Stephen,Garcia-Alonso Angel,Fyfe David W,Hubner Richard A,Gamble Tina,Peachey Lynnda,Davoudianfar Mina,Pearson Sarah R,Julier Patrick,Jankowski Janusz,Kerr Rachel,Petty Russell D

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. Global patterns of cancer incidence and mortality rates and trends;Jemal;Cancer Epidemiol Biomarkers Prev,2010

2. Cancer survival in England: patients diagnosed 2006–2010 and followed up to 2011,2012

3. Gastroesophageal cancers: progress and problems;Ajani;J Natl Compr Canc Netw,2008

4. Current management of esophageal squamous-cell carcinoma in Japan and other countries;Higuchi;Gastrointest Cancer Res,2009

5. Palliative treatments of carcinoma of oesophagus and stomach;Blazeby,2013

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3